Caloric restriction increases adiponectin in humans (participants in the caloric restriction and usual activity arm, moderate to severe CKD) (+23% (95% CI 0.2% to 49.8%)).
“Plasma adiponectin levels increased significantly in response to diet by 23% (95% CI: 0.2%, 49.8%, p = 0.048)”
Human trialparticipants in the caloric restriction and usual activity arm, moderate to severe CKD10%-15% reduction in caloric intake
Nutrition, metabolism, and cardiovascular diseases : NMCD·
Caloric restriction showed no clear effect on adiponectin in humans (obesity).
“A moderate dietary intervention did not correct adiponectin, antioxidant status, vWF, TM, and plasminogen activator inhibitor-1 (PAI-1) but ameliorated changes in other parameters.”
Human trialobesity15 - 30% energy deficitserum8 weeksfemalesn = 41
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism·
Caloric restriction increases adiponectin in rats (on high-sodium diet).
“CR in rats on a high-sodium diet improved metabolic parameters, renal transforming growth factor-β and collagen-1α1 and increased plasma adiponectin and renal visfatin and NAD+ protein levels.”
Animalson high-sodium dietplasma60% of caloric intake4 weeks
Testosterone decreases adiponectin in humans (added to lifestyle therapy) (−408 ± 489 ng/mL vs 1832 ± 468 ng/mL).
“On the other hand, although adiponectin levels increased in the LT + Pbo group (1832 ± 468 ng/mL [16% change from baseline]), no significant change was observed in the LT + TRT group (−408 ± 489 ng/mL [4% change]).”
Human trialadded to lifestyle therapy26 weeksmalesn = 83
The Journal of clinical endocrinology and metabolism·
Testosterone decreases adiponectin in humans (older men with obesity and hypogonadism receiving lifestyle therapy) (-408 ± 489 ng/mL vs 1832 ± 468 ng/mL, P = .02).
“and adiponectin levels (-408 ± 489 ng/mL in LT + TRT group vs 1832 ± 468 ng/mL in LT + Pbo group, P = .02).”
Human trialolder men with obesity and hypogonadism receiving lifestyle therapy6 monthsmalesn = 83
“Levels of adiponectin, an anti-inflammatory cytokine, in the placebo-treated group were virtually unchanged, whereas those of the curcumin-treated group were gradually elevated (at 3 and 6 months) and became significantly different from that of placebo-treated group at the final visit (9 months).”
↑upin humans2↑upin F. catus1↔no changein humans1↑upin pigs1
5 studies
Resveratrol showed no clear effect on adiponectin in humans (patients with nonalcoholic fatty liver disease).
“No significant differences were observed in the serum levels of PAI-1, adiponectin, FGF-21, and hs-CRP between the two groups at the end of the study.”
Human trialpatients with nonalcoholic fatty liver diseasecapsule12 weeksn = 50
“Meta-analysis of data from 10 treatment arms showed a significant change in plasma adiponectin concentrations following resveratrol supplementation (WMD: 1.10μg/ml, 95%CI: 0.88, 1.33, p<0.001)”
Melatonin increases adiponectin in obese patients on a calorie-restricted diet.
“Thirty days of melatonin supplementation resulted in the significant increases in the serum adiponectin and omentin-1 concentrations, as well as the erythrocytic GPx activities.”
Human trialin obese patients on a calorie-restricted diet30 days
Melatonin increases adiponectin in mice (SAMP8 mice).
“Decreased expression of adiponectin and adiponectin receptor 1 was also observed in visceral fat of untreated SAMP8, whereas a significant increase was observed after melatonin treatment.”
Resistance training decreases adiponectin in humans (both leucine and placebo groups during 10-week resistance training) (LEU 652 ± 513 to 292 ± 447 pg/ml; PLC 584 ± 572 to 245 ± 356 pg/ml; p = 0.002).
“There were significant decreases in adiponectin concentrations in both groups”
Human trialboth leucine and placebo groups during 10-week resistance training10 weeksfemalesn = 35
High-intensity interval training increases adiponectin in humans after 4 weeks of detraining (1.78-fold vs control).
“However, after four weeks of detraining, the adiponectin concentration remained 1.78-fold in the L-HIIT group than in the control group (p=0.033, ES=0.157).”
High-intensity interval training increases adiponectin in humans (overweight) (1.78 times higher).
“following a four-week detraining stage, the adiponectin concentration remained 1.78 times higher in the L-HIIT group than in the control group (p=0.033).”
Human trialoverweight4 × 4 min Exercise/4 min Rest4 weeks detraining
Cholecalciferol increases adiponectin in adult epilepsy patients treated with enzymatic antiseizure medications (1.38 ± 3.05 vs. 0.34 ± 1.89 μg/mL).
“Vitamin D supplementation yielded a significantly greater increase in serum 25(OH)D (10.67 ± 8.16 vs. –1.29 ± 3.96 ng/mL; p < 0.001) and adiponectin (1.38 ± 3.05 vs. 0.34 ± 1.89 μg/mL; p = 0.045)”
Human trialin adult epilepsy patients treated with enzymatic antiseizure medications2,000 IU/day12 weeks
Cholecalciferol increases adiponectin in humans (adjusted for baseline values, season, sun exposure, and dietary vitamin D intake) (β[95%CI] = 13.7[2.0, 25.5], p = 0.02).
“there was a greater increase in adiponectin (β[95%CI] = 13.7[2.0, 25.5], p = 0.02) and leptin (β[95%CI] = 22.3[3.8, 40.9], p = 0.02) in the vitamin D group compared with placebo”
Human trialadjusted for baseline values, season, sun exposure, and dietary vitamin D intake16 weeks
Omega-3 fatty acids increase adiponectin in humans (prediabetes or type 2 diabetes; effect not robust in sensitivity analysis) (0.48 μg/mL; 95% CI 0.27 to 0.68).
“Omega-3 supplementation increased levels of adiponectin (0.48 μg/mL; 95% confidence interval [CI], 0.27 to 0.68; P<0.00001, n=10 trials)”
Reviewprediabetes or type 2 diabetes; effect not robust in sensitivity analysisn = 685
International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition·
Coenzyme Q10 showed no clear effect on adiponectin in humans.
“Both CoQ10 and placebo supplementation did not affect plasma adiponectin and TNF-alpha levels.”
Fish oil increases adiponectin in humans (+45 TT genotype) (+22%).
“Individuals homozygous for the +45 T-allele aged >58 y had a 22% increase in serum adiponectin concentration compared with baseline after the highest dose (P-treatment effect = 0.008).”
Fish oil increases adiponectin in humans (overweight subjects) (+0.55 μg/mL (95% CI 0.02–1.08)).
“Serum adiponectin levels were increased by 0.55 μg/mL (95% confidence interval, 0.02-1.08) in the fish oil group compared with the control group (P = .04) after 6 weeks of supplementation.”
Human trialoverweight subjectsserum2 g/day (1.1 g marine n-3 PUFA)6 weeksn = 50
“Moreover, the increase in serum adiponectin, CTRP3, and CTRP5 from baseline to 8 wk was significantly higher in the training group compared with the control group”
“Adiponectin is a fat-derived hormone whose reduction plays central roles in obesity-linked diseases including insulin resistance/type 2 diabetes and atherosclerosis.”
Adiponectin is linked with less perioperative neurocognitive disorder in humans (elderly patients undergoing thoracic surgery) (HR 0.307, 95% CI 0.113-0.835, p = 0.021).
“High serum APN, AQP4, and BDNF levels were independent protective factors for PND”
Vitamin D was not clearly linked with adiponectin in humans (obese pre- and early postmenopausal women) (r = -0.008 (premenopausal), r = -0.135 (postmenopausal)).
“There was no significant correlation between serum adiponectin and 25(OH)D in either group (r = -0.008, P = 0.949 in the premenopausal group; r = -0.135, P = 0.312 in the postmenopausal group).”
Humansobese pre- and early postmenopausal womenserumfemalesn = 118
Type 2 diabetes is linked with lower adiponectin in humans (newly diagnosed T2DM compared with PreDM) (22.05 vs. 30.30 and 25.72 vs. 38.84, p < 0.0001).
“Both adiponectin and omentin levels were lower in T2DM compared with PreDM (22.05 vs. 30.30 and 25.72 vs. 38.84, p < 0.0001 for both).”
KIDMUTATION increases adiponectin in mice (variable across mice).
“At 4 months, these mice variably display hormonal markers that associate with successful aging counteraction, including elevated adiponectin and FGF21”
Senile osteoporosis showed no clear effect on adiponectin in humans (compared with healthy older individuals with normal bone mineral density) (MD -0.55, 95% CI: -2.26 to 1.17, P = 0.53).
“adiponectin levels were not significantly different (MD, -0.55, 95% CI: -2.26 to 1.17, P = 0.53, I2 = 98%)”
Reviewcompared with healthy older individuals with normal bone mineral densityserum
Cryptorchidism increases adiponectin in dogs (expression in pathological testes (cryptorchid and germ cell tumor)).
“Increased expression of adiponectin and adiponectin receptor 1, as well as extracellular signal-activated kinase (ERK1/2) in pathological testes were detected.”
Animalsexpression in pathological testes (cryptorchid and germ cell tumor)testismales
Frailty is associated with adiponectin in patients with stable CAD (AUC=0,766; 95% confidence interval: 0,643-0,889, p=0,013).
“Binary logistic regression confirmed a significant association between the frailty according to the "Age is not a barrier" questionnaire and lower serum adiponectin levels in patients with stable CAD”
“Frail older adults showed higher levels of BUN, IL-6, adiponectin, vaspin, and glucose and lower levels of IGF-1, HDL, and HGB compared with nonfrail participants.”
Adiponectin is associated with cognitive function in humans (obesity) (p = 0.731; r < 0.01 (as reported; statistical significance is inconsistently reported)).
“this study found that adiponectin levels were associated with cognitive function in the obese elderly population examined.”
Adiponectin is linked with a lower risk of type 2 diabetes in humans (adjusted for covariates; p=0.03 for interaction by gender) (OR: 0.31; 95% CI: 0.19-0.72).
“lower odds of diabetes in women (OR: 0.31; 95% CI: 0.19-0.72; p=0.03 for interaction by gender)”
Humansadjusted for covariates; p=0.03 for interaction by genderfemalesn = 891
Adiponectin is associated with cardiovascular mortality in humans (Without baseline cardiovascular disease; highest versus lowest adiponectin quartile) (Q4 versus Q1: HR 2.43, 95% CI 1.15–5.15).
“CVD mortality Q4 versus Q1 (HR = 2.43; 95% CI 1.15, 5.15)”
Adiponectin predicts mortality in humans (patients undergoing transcatheter aortic valve implantation) (HR 4.155 (95% CI: 1.364-12.655), p = .004).
“Compared with patients with the lowest adiponectin level, patients in the third tertile had a hazards ratio of all-cause mortality after TAVI of 4.155 (95% CI: 1.364-12.655) (p = .004).”
Adiponectin is associated with mortality in humans (Without baseline cardiovascular disease; highest versus lowest adiponectin quartile) (Q4 versus Q1: HR 2.27, 95% CI 1.47–3.50).
“increasing adiponectin quartiles were positively associated with all-cause mortality Q4 versus Q1 (hazard ratio [HR] = 2.27; 95% confidence interval [CI] 1.47, 3.50)”
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·
Adiponectin is associated with muscle mass in humans (r = -0.296; p = 0.001).
“plasma adiponectin levels negatively correlated with BMI (r = -0.129; p = 0.03), lean mass (r = -0.252; p = 0.001), muscle mass (r = -0.296; p = 0.001)”
Adiponectin is associated with triglyceride in young MASLD patients (r = -0.95, p < 0.001).
“Strong inverse correlation was found between the adiponectin and total lactate dehydrogenase activity (r = -0.81, p < 0.05), GGT (r = -0.93, p = 0.008) and the triacylglycerols content (r = -0.95, p < 0.001) in the blood in young patients.”
ADIPOQ is associated with adiponectin in humans (GG genotype of rs1501299, after both hypocaloric diets) (Diet P: 9.3±3.0 ng/dl vs. Diet M: 8.2±2.9 ng/dl: p=0.38).
“Only subjects with GG genotype showed a significant increase of the adiponectin levels after both diets”
Human trialGG genotype of rs1501299, after both hypocaloric diets12 weeks
Adiponectin is associated with lean mass in humans (-5.0% (95% CI: -9.4%, -2.4%)).
“Lean mass declined by 5.0% (95% CI: -9.4%, -2.4%) in the adjusted model and by 13.4% (95% CI: -17.4%, -9.3%) in the unadjusted model.”
Human trialper twofold increase in adiponectin over 36 months, after adjusting for procedure, age, and sex3 years (surgical groups) or 2 years (Diet group)n = 55
Handgrip strength was an estimated 3.71 kilograms higher with resistance training than in controls after 24 weeks; both exercise programs improved other fitness tests.Handgrip strength was an estimated 3.71 kilograms higher with resistance training than in controls after 24 weeks; both exercise programs improved other fitness tests.
In a two-year randomized controlled trial of 326 healthy older adults, daily walnuts had little effect on body composition compared with avoiding walnuts.In a two-year randomized controlled trial of 326 healthy older adults, daily walnuts had little effect on body composition compared with avoiding walnuts.